article Open AccessTop 1% cited

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

Gynecologic Oncology · 2015 · Vol. 136(2) · pp. 189–197

Thomas C. Wright✉(Columbia University)Mark H. Stoler✉(University of Virginia)Catherine Behrens✉(Materials Systems (United States))Abha Sharma✉(Materials Systems (United States))Guili Zhang✉(Materials Systems (United States))Teresa L. Wright✉

View via DOI Full-text PDF

Abstract

HPV primary screening in women ≥25years is as effective as a hybrid screening strategy that uses cytology if 25-29years and cotesting if ≥30years. However, HPV primary screening requires less screening tests.

Cervical Cancer and HPV Research Genital Health and Disease Endometrial and Cervical Cancer TreatmentsColposcopyMedicineCytologyGynecologyCervical cancerCervical intraepithelial neoplasiaCervical screeningPapillomaviridaeObstetricsCancer

MeSH terms

AdultUterine Cervical DysplasiaUterine Cervical NeoplasmsFemaleHumansMass ScreeningVaginal SmearsPapillomaviridaePapillomavirus InfectionsEarly Detection of Cancer

Citations

578

FWCI

42.96

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society